Get in on the ground floor of groundbreaking medical technology. We look forward to working with you!

Over the last few years, Phagencorp has been hard at work discovering and researching Induced Native Phage Therapy, or the use of native phages, or phages that already reside in a person’s body, in order to eliminate the host microbe—and infection—in the process. In fact, we are now accepting applications from doctors wishing to conduct independent IRB studies. If you or your medical team are interested in working with us to finalize this never-before-seen treatment initiative, we are very interested in hearing from you. Please complete the questionnaire below to get started!

Research Prequalification Questionnaire

[gravityform id=”6″ title=”false” description=”false” ajax=”false” /]

By submitting my data I agree to be contacted at the email address and/or phone number provided.


In December of 2021, we were excited to present our strong, peer-reviewed, retrospective, proof of concept research of Inducen-LD/RF to the world. In this publication, we demonstrated the apparent rapid elimination of Borrelia strains, using the latest and most sensitive lab testing, coinciding with significant clinical improvements in many participants suffering with previously treatment-resistant Borrelia infections.

To ensure absolute credibility of our innovation, and the industry as a whole, we feel that the completion of the double-blinded, independent research study, and the ongoing independent product research taking place both in the U.S. and Europe, is necessary before the product is released to healthcare practitioners. We apologize for the delay, however our goal is to ensure the highest integrity of the science, and the accuracy of or subsequent modifications of the concepts and representations.